Viatris Inc. (VTRS) Presents at Goldman Sachs 46th Annual Global Healthcare Conference Transcript

Company Overview - Viatris Inc. is currently experiencing strong performance in its base business, with 8 to 9 consecutive quarters of operational revenue growth despite some manufacturing issues at a specific plant [2][3] - The company has exceeded initial guidance for total new product revenue in the previous year, indicating effective execution of its product strategy [2] Financial Performance - Viatris has been actively engaging in capital allocation strategies, including paying dividends and share buybacks, with over $300 million spent on share repurchases to date [3]